Target therapies in pancreatic carcinoma. [electronic resource]
Producer: 20140929Description: 948-65 p. digitalISSN:- 1875-533X
- Albumins -- therapeutic use
- Animals
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Bevacizumab
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Hedgehog Proteins -- antagonists & inhibitors
- Humans
- Matrix Metalloproteinases -- metabolism
- Molecular Targeted Therapy -- methods
- Paclitaxel -- therapeutic use
- Pancreas -- drug effects
- Pancreatic Neoplasms -- drug therapy
- Quinazolines -- therapeutic use
- Receptor, IGF Type 1 -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.